Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Vericel (VCEL) has a market cap of $2.11 billion USD. According to our data, Vericel is ranked No.3897 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $2.11 B |
-22.28%
|
| Dec 31, 2024 | $2.71 B |
54.20%
|
| Dec 29, 2023 | $1.76 B |
35.19%
|
| Dec 30, 2022 | $1.30 B |
-32.98%
|
| Dec 31, 2021 | $1.94 B |
27.27%
|
| Dec 31, 2020 | $1.52 B |
77.47%
|
| Dec 31, 2019 | $0.86 B |
0.00%
|
| Dec 31, 2018 | $0.86 B |
219.27%
|
| Dec 29, 2017 | $0.27 B |
81.67%
|
| Dec 30, 2016 | $0.15 B |
16.28%
|
| Dec 31, 2015 | $0.13 B |
-15.13%
|
| Dec 31, 2014 | $0.15 B |
-5.88%
|
| Dec 31, 2013 | $0.16 B |
-87.18%
|
| Dec 31, 2012 | $1.24 B |
-30.77%
|
| Dec 30, 2011 | $1.80 B |
-28.91%
|
| Dec 31, 2010 | $2.53 B |
3.23%
|
| Dec 31, 2009 | $2.45 B |
-38.00%
|
| Dec 31, 2008 | $3.95 B |
-3.85%
|
| Dec 31, 2007 | $4.11 B |
-57.72%
|
| Dec 29, 2006 | $9.71 B |
-41.71%
|
| Dec 30, 2005 | $16.66 B |
48.59%
|
| Dec 31, 2004 | $11.21 B |
6.77%
|
| Dec 31, 2003 | $10.50 B |
182.98%
|
| Dec 31, 2002 | $3.71 B |
-52.04%
|
| Dec 31, 2001 | $7.74 B |
12.00%
|
| Dec 29, 2000 | $6.91 B |
12.00%
|
| Dec 31, 1999 | $6.17 B |
-72.83%
|
| Dec 31, 1998 | $22.70 B |
-34.29%
|
| Dec 31, 1997 | $34.55 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Organogenesis
ORGO
|
$0.55 B |
-0.000 M
|
USA
|
 MiMedx Group
MDXG
|
$1.00 B |
0.000 M
|
USA
|
 Integra LifeSciences
IART
|
$1.24 B |
-0.000 M
|
USA
|
 Smith & Nephew
SNN
|
$11.39 B |
0.000 M
|
UK
|
 Zimmer Biomet
ZBH
|
$19.24 B |
0.000 M
|
USA
|
 Stryker Corporation
SYK
|
$132.37 B |
-0.002 M
|
USA
|
 Medtronic
MDT
|
$105.64 B |
0.002 M
|
Ireland
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Baxter
BAX
|
$14.26 B |
0.000 M
|
USA
|
 Boston Scientific
BSX
|
$139.37 B |
0.007 M
|
USA
|
 Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
USA
|
 Edwards Lifesciences
EW
|
$41.45 B |
0.000 M
|
USA
|
 Orthofix Medical
OFIX
|
$0.52 B |
-0.000 M
|
USA
|
| Market Cap | = | VCEL Stock Price | * | VCEL Shares Outstanding |
| = | $42.01 | * | 50.14 M | |
| = | $2.11 B |